tykhr
sign in
free sign up
Merrimack Pharmaceuticals Inc
Biotechnology
Healthcare
MACK
14.29 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
13.40
52 week high
13.41
high
13.47
52 week low
10.12
low
13.19
growth
10.00 %
previous Close
13.41
P/E ratio
market cap
177 M
div yield
0
usd
Jun 2023
qoq
revenue
0.00 %
net incoming
-391.00 K
-311.58 %
eps
0.00 %
-37.00 %
eps surprise
0.00 %
net profit margin
-39100000.00 %
0.00 %
operating incoming
-569.00 K
-27.29 %
net change in cash
-9.27 M
-24.00 %
cash on hand
10.13 M
-47.78 %
cost of revenue
0.00 %
top